Vivoryon Therapeutics N.V. (LON:0R3M)
London flag London · Delayed Price · Currency is GBP · Price in EUR
1.456
+0.016 (1.11%)
At close: Jul 9, 2025

Vivoryon Therapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
3343184221319161
Upgrade
Market Cap Growth
-76.70%-76.70%-16.55%-30.94%98.13%75.13%
Upgrade
Enterprise Value
2530151199303131
Upgrade
Last Close Price
1.251.657.079.2315.548.15
Upgrade
PS Ratio
---58.61-35.34-
Upgrade
PB Ratio
5.036.588.079.3922.986.86
Upgrade
P/TBV Ratio
5.657.408.379.5623.747.02
Upgrade
EV/Sales Ratio
----33.52-
Upgrade
Debt / Equity Ratio
0.010.010.000.010.010.01
Upgrade
Asset Turnover
----0.40-
Upgrade
Quick Ratio
6.936.939.309.353.5719.95
Upgrade
Current Ratio
7.207.209.379.404.0121.73
Upgrade
Return on Equity (ROE)
-120.41%-120.41%-107.38%-130.77%-59.17%-47.93%
Upgrade
Return on Assets (ROA)
-62.22%-62.22%-57.95%-65.10%-29.48%-26.47%
Upgrade
Return on Capital (ROIC)
-76.38%-76.38%-68.07%-83.81%-36.94%-28.75%
Upgrade
Earnings Yield
-51.88%-39.65%-13.36%-11.32%-3.33%-9.17%
Upgrade
FCF Yield
-48.37%-36.97%-10.16%-8.77%-2.96%-7.82%
Upgrade
Buyback Yield / Dilution
-3.27%-3.27%-14.64%-10.10%-0.12%-59.17%
Upgrade
Updated Sep 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.